NewsWhore
12-24-2009, 01:20 PM
AstraZeneca for $350 million. The Waltham, Mass.-based venture capital firm is one of several investors in Paris, France-based Novexel. Novexel was spun out of
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/30804937/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/30804937/)